Details

NameSymbolSector
PARNAX LAB LIMITEDPARNAXLABPharmaceuticals
Open
128
High
128
Low
126
Close
126.05
Volume
972
Exchange
bse
Time
08-Sep-2026

Outlook

Score:  

0.25

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Parnax Lab is  
Marubozu
Estimated Stoploss of Parnax Lab is ₹  
128
Parnax Lab has a  
Bearishℹ
 pattern. 
Formation of  
Marubozu
 candle pattern indicates Parnax Lab has chances of  
Continuationℹ
 of the current trend. 

Trend

Parnax Lab is in  
Sideways trendℹ
. 
Price of Parnax Lab is  
Downℹ
 by  

6.77

%. 
Target
Buy @ 

117.86

Sell @ 

154.02

Current @ 

126.05

Volume

The trade volumes of Parnax Lab have become  
Deficientℹ
The volume trend for Parnax Lab is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Parnax Lab is  

Down

 by  

83.43

% 

Valuation

The current market price of Parnax Lab is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 189cr and total assets worth ₹ 189cr, the balance sheet of Parnax Lab is:  
Balancedℹ
. 
Cashflow
Parnax Lab has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2025)

50.79% i.e. ₹ 32cr earned in operatingℹ
25.4% i.e. ₹ 16cr spent in investingℹ
23.81% i.e. ₹ 15cr spent in financingℹ
0% in otherℹ
Parnax Lab has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Upℹ
 by  

100

%. 

(*Mar 2024)

25% i.e. ₹ 15cr earned in operatingℹ
51.67% i.e. ₹ 31cr spent in investingℹ
23.33% i.e. ₹ 14cr earned in financingℹ
0% in otherℹ
Income
The income of Parnax Lab is  

₹ 63cr

 and  

Profit

 is :  

₹ 3cr

(*Sep 2025)

Parnax Lab Profit is up by:  

0

% and Income is Up by:  

18.87

% 

(*Sep 2025)

The income of Parnax Lab is  

₹ 53cr

 and  

Profit

 is :  

₹ 3cr

(*Jun 2025)

Parnax Lab Profit is up by:  

50

% and Income is Up by:  

8.16

% 

(*Jun 2025)

The income of Parnax Lab is  

₹ 49cr

 and  

Profit

 is :  

₹ 2cr

(*Mar 2025)

Parnax Lab Profit is up by:  

100

% and Income is Up by:  

22.5

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.